Roberto Bravo-Sagua

Dr. Roberto Bravo-Sagua

INTA, Universidad de Chile, Santiago, Región Metropolitana, Chile
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Journal of Cell Science
Verified
Journal Article
Closed access
PDF file
RBRoberto Bravo-Sagua
Roberto Bravo-Sagua
JVJose Miguel Vicencio
Jose Miguel Vicencio
VPValentina Parra
Valentina Parra
RTRodrigo Troncoso
Rodrigo Troncoso
JMJuan Pablo Muñoz
Juan Pablo Muñoz
SLSergio Lavandero
Sergio Lavandero
Increasing evidence indicates that endoplasmic reticulum (ER) stress activates the adaptive unfolded protein response (UPR), but that beyond a certain degree of ER damage, this response triggers apoptotic pathways. The general mechanisms of the UPR and its apoptotic pathways are well characterized. However, the metabolic events that occur during the adaptive phase of ER stress, before the cell death response, remain unknown. Here, we show that, during the onset of ER stress, the reticular and mitochondrial networks are redistributed towards the perinuclear area and their points of connection are increased in a microtubule-dependent fashion. A localized increase in mitochondrial transmembrane potential is observed only in redistributed mitochondria, whereas mitochondria that remain in other subcellular zones display no significant changes. Spatial re-organization of these organelles correlates with an increase in ATP levels, oxygen consumption, reductive power and increased mitochondrial Ca2+ uptake. Accordingly, uncoupling of the organelles or blocking Ca2+ transfer impaired the metabolic response, rendering cells more vulnerable to ER stress. Overall, these data indicate that ER stress induces an early increase in mitochondrial metabolism that depends crucially upon organelle coupling and Ca2+ transfer, which, by enhancing cellular bioenergetics, establishes the metabolic basis for the adaptation to this response.

1 January 2013
Verified
Book Chapter
Closed access
RBRoberto Bravo-Sagua
Roberto Bravo-Sagua
VPValentina Parra
Valentina Parra
DGDamián Gatica
Damián Gatica
ARAndrea E Rodriguez
Andrea E Rodriguez
NTNatalia Torrealba
Natalia Torrealba
SLSergio Lavandero
Sergio Lavandero

16 March 2017
Verified
Book Chapter
Closed access
PDF file
RBRoberto Bravo-Sagua
Roberto Bravo-Sagua
VPValentina Parra
Valentina Parra
CLCamila López‐Crisosto
Camila López‐Crisosto
PDPaula Díaz
Paula Díaz
AQAndrew F. G. Quest
Andrew F. G. Quest
SLSergio Lavandero
Sergio Lavandero

1 January 2012 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
RBRoberto Bravo-Sagua
Roberto Bravo-Sagua
TGTomás Gutierrez
Tomás Gutierrez
FPFelipe Paredes
Felipe Paredes
DGDamián Gatica
Damián Gatica
ARAndrea E. Rodriguez
Andrea E. Rodriguez
SLSergio Lavandero
Sergio Lavandero

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YÁYenniffer Ávalos
Yenniffer Ávalos
JCJimena Canales
Jimena Canales
RBRoberto Bravo-Sagua
Roberto Bravo-Sagua
ACAlfredo Criollo
Alfredo Criollo
SLSergio Lavandero
Sergio Lavandero
AQAndrew FG Quest
Andrew FG Quest
Autophagy is a highly regulated catabolic process that involves lysosomal degradation of proteins and organelles, mostly mitochondria, for the maintenance of cellular homeostasis and reduction of metabolic stress. Problems in the execution of this process are linked to different pathological conditions, such as neurodegeneration, aging, and cancer. Many of the proteins that regulate autophagy are either oncogenes or tumor suppressor proteins. Specifically, tumor suppressor genes that negatively regulate mTOR, such as PTEN, AMPK, LKB1, and TSC1/2 stimulate autophagy while, conversely, oncogenes that activate mTOR, such as class I PI3K, Ras, Rheb, and AKT, inhibit autophagy, suggesting that autophagy is a tumor suppressor mechanism. Consistent with this hypothesis, the inhibition of autophagy promotes oxidative stress, genomic instability, and tumorigenesis. Nevertheless, autophagy also functions as a cytoprotective mechanism under stress conditions, including hypoxia and nutrient starvation, that promotes tumor growth and resistance to chemotherapy in established tumors. Here, in this brief review, we will focus the discussion on this ambiguous role of autophagy in the development and progression of cancer.

9 March 2017 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
CLCamila Lopez-Crisosto
Camila Lopez-Crisosto
CPChristian Pennanen
Christian Pennanen
CVCésar Alonso Vásquez-Trincado
César Alonso Vásquez-Trincado
PMPablo E. Morales
Pablo E. Morales
RBRoberto Bravo-Sagua
Roberto Bravo-Sagua
SLSergio Lavandero
Sergio Lavandero